Stay updated on Cabozantinib for PN in NF1: Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for PN in NF1: Clinical Trial page.

Latest updates to the Cabozantinib for PN in NF1: Clinical Trial page
- ChecktodayChange DetectedThe page now shows revision v3.6.4 instead of v3.6.3, indicating a minor metadata update to the page.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page revision has been updated from v3.6.2 to v3.6.3, indicating a backend/documentation update. No study details, eligibility criteria, outcomes, or visible content were altered.SummaryDifference0.0%

- Check29 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.2 on the page. This indicates an internal update to the release, with no explicit changes to the displayed study content.SummaryDifference0.0%

- Check43 days agoChange DetectedThe page now marks recruitment as closed. New help sections (How to Read a Study Record, Common Questions, How to Join a Study) appear, the Intervention/Treatment heading is standardized, and the revision tag updates to v3.6.0.SummaryDifference0.4%

- Check50 days agoChange DetectedThe page's revision line updated from v3.5.4 to v3.5.5, indicating a new revision release. This update reflects an administrative version bump rather than a substantive change to study details or content.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page's revision label was updated from Revision: v3.5.3 to Revision: v3.5.4, signaling a new document version on the page.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib for PN in NF1: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for PN in NF1: Clinical Trial page.